Image3

Cowen Downgrades Ionis After Thrombocytopenia Issues

Ionis Pharmaceuticals Inc IONS 39.42% shares are tanking nearly 40 percent on Thursday following the company’s disclosure that severe cases of thrombocytopenia have been associated with two of its major drug programs: TTR in FAP and APOC3 in FCS. Cowen & Co analyst Eric Schmidt has downgraded the stock on the uncertainty surrounding the incidents…

Image4

Oppenheimer Thinks Alibaba SEC Probe Already Priced In

The market may not have known about the SEC’s investigation of Alibaba Group Holding Ltd BABA 3.65% until the company’s recent disclosure, but the market may very well have priced in the issues a long time ago. According to Oppenheimer analyst Jason Helfstein, the elements of Alibaba’s business that the SEC is looking into have…

Image5

Goldman Sees These 3 Areas Leading The Oil Market Recovery

Brent crude oil prices topped $50/bbl on Thursday for the first time in nearly seven months, providing further evidence that the oil market has found its bottom for this cycle. Now that the market appears to be stabilizing, investors are shifting their focus to which stocks will be the best performers throughout the recovery.